Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02070081
Other study ID # GO Bypass
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 2014
Est. completion date April 2017

Study information

Verified date May 2019
Source University of Copenhagen
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The overall aim is to study the multiple factors determining the variation of weight loss after Roux-en-Y Gastric Bypass (RYGB) and Sleeve surgery.

The specific aims are to evaluate:

a) what explains the large individual differences in weight loss seen after RYGB and Sleeve surgery, b) if it is possible pre-operatively to identify which patients will not obtain beneficial effects of bariatric surgery in relation to weight loss and quality of life and c) if patients in need of improved care can be identified pre- and/or early post-operatively.


Recruitment information / eligibility

Status Completed
Enrollment 55
Est. completion date April 2017
Est. primary completion date April 2017
Accepts healthy volunteers No
Gender All
Age group 25 Years to 65 Years
Eligibility Inclusion Criteria:

- All patients approved for bariatric surgery at Bariatric Clinic, Køge Hospital, Denmark

Exclusion Criteria:

- Inability to comply with the study protocol

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Roux-en-Y gastric bypass surgery or sleeve surgery


Locations

Country Name City State
Denmark Faculty of Science, NEXS Frederiksberg

Sponsors (3)

Lead Sponsor Collaborator
University of Copenhagen Bariatric Clinic, Department of Surgery, Køge Hospital, Denmark, The Danish Research Centre for Magnetic Resonance, Hvidovre Hospital, Denmark

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Primary Weight loss 3 month preoperatively, 1 week preoperatively, 6 weeks postoperatively, 6 month postoperatively and 18 month postoperatively
Secondary Metabolic profile Insulin, glucose, C-peptide, GIP, glucagon, TSH, thyroid hormones, vitamin D and blood lipids 3 month preoperatively, 1 week preoperatively, 6 month postoperatively and 18 month postoperatively
Secondary Physical activity 3 month preoperatively, 1 week preoperatively, 6 month postoperatively and 18 month postoperatively
Secondary Appetite sensation Following a test meal with the use of visual analogue scales (VAS) 3 month preoperatively, 1 week preoperatively, 6 weeks postoperatively, 6 month postoperatively and 18 month postoperatively
Secondary Taste preferences and taste perception Sensory tests, picture displays (all visits) and an ad libitum test meals (3 months preoperatively and 6 months postoperatively) are used to investigate changes in taste and food preferences (liking and wanting) and taste perception 3 month preoperatively, 1 week preoperatively, 6 weeks postoperatively, 6 month postoperatively and 18 month postoperatively
Secondary Mental health 3 month preoperatively, 6 month postoperatively and 18 month postoperatively
Secondary Social resources 3 month preoperatively, 1 week preoperatively, 6 weeks postoperatively, 6 month postoperatively and 18 month postoperatively
Secondary Gut microbiota 1 week preoperatively, 6 month postoperatively
Secondary Appetite-regulating hormones GLP-1, PYY, leptin, ghrelin, OXM, CCK, glicentin 3 month preoperatively, 1 week preoperatively, 6 month postoperatively and 18 month postoperatively
Secondary Bile acids and fibroblast growth factors 3 month preoperatively, 1 week preoperatively, 6 month postoperatively and 18 month postoperatively
Secondary Genetics 3 month preoperatively
Secondary Body composition By DXA scans 3 month preoperatively, 1 week preoperatively, 6 weeks postoperatively, 6 month postoperatively and 18 month postoperatively
Secondary Cortisol Measured in hair 3 month preoperatively and 18 month postoperatively
Secondary Neural activity in reward-processing brain centers By functional magnetic resonance imaging (fmri) preoperatively and 6 month postoperatively
Secondary Rewarding value of food Behavioral test preoperatively and 6 month postoperatively
See also
  Status Clinical Trial Phase
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2